Clinical Trials Directory

Trials / Unknown

UnknownNCT01045720

The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia

The Treatment Effect of 2 Traditional Chinese Medicines[Suo Quan Wan]and [Wu Lin San] in Clozapine-induced Hypersalivation in Schizophrenia Patient.

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The goal of this research is hoping to combine traditional Chinese medicine medication and find out how to solve clozapine-induced hypersalivation, also reduce side-effect, medication compliance, improving life quality, improving social-function and reducing neopathy.

Detailed description

Clozapine, an antipsychotic drug, is an important clinical medicine which is used for schizophrenia and preventing for its relapse; clozapine is better than some other atypical antipsychotics. However, in clinical uses, clozapine often could induce hypersalivation, it is not only influencing patient's appearance, also deteriorating sleeping quality which could deter patient discontinuing to take medicine. In previous researches, Suo Quan Wan and Wu Lin San had been proven effective for hypersalivation and no significant side-effects, nevertheless, it still lack of systematical scientific trial reports. The ingredients of Suo Quan Wan are Wu Yao, San Yao and Yi Zhi Ren; the ingredients of Wu Lin San are Gui Zhi, Fu Ling, Zhu Ling, Ze Xie and Bai Ju, both have bi-directional regulatory functions for body fluid and saliva. The goal of this research is hoping to combine traditional Chinese medicine medication and find out how to solve clozapine-induced hypersalivation, also reduce side-effect, medication compliance, improving life quality, improving social-function and reducing neopathy.

Conditions

Interventions

TypeNameDescription
DRUGSuo Quan Wan, Wu Lin SanSuo Quan Wan Wu Lin San Placebo 2/daily
DRUGPlaceboPlacebo (starch)

Timeline

Start date
2010-01-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2010-01-11
Last updated
2010-01-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01045720. Inclusion in this directory is not an endorsement.